Extending the indication of transcatheter aortic valve replacement (TAVR) to younger and
lower-risk patients naturally results in longer life expectancy and survival rates after the …

Background: Scarce data exist on coronary events following transcatheter aortic valve
replacement (TAVR), and no study has determined the factors associated with poorer …

Objectives: The authors sought to assess the incidence, predictors, management, and
prognosis of acute coronary syndrome (ACS) following TAVR. Background: About one-half …

Objectives This study sought to address a knowledge gap by examining the incidence,
timing, and predictors of acute coronary syndrome (ACS) after transcatheter aortic valve …

Coronary artery disease (CAD) is prevalent in patients who undergo transcatheter aortic
valve replacement (TAVR), with estimated rates as high as 80% in populations at high risk …

Acute coronary syndrome (ACS) encompasses a broad category of presentations from
unstable angina to ST-elevation myocardial infarctions. Most patients undergo coronary …

Background Incidence and outcomes of acute coronary syndrome (ACS) immediately
following transcatheter aortic valve replacement (TAVR) remain largely unknown. Objectives …

Background Among patients with acute coronary syndrome following transcatheter aortic
valve replacement (TAVR), those presenting with ST-segment elevation myocardial …

Objectives This study aimed to evaluate the incidence, treatment, and outcomes of acute
myocardial infarction (AMI) following transcatheter or surgical aortic valve replacement …

Coronary artery disease is the most frequent comorbidity in patients undergoing
transcatheter aortic valve replacement (TAVR), with a prevalence ranging from 50% to 80 …